Results

Total Results: 1,140 records

Showing results for "diabetes".
Users also searched for: diabetes

121. National Action Plan for Adverse Drug Event Prevention. | PSNet
     psnet.ahrq.gov/issue/national-action-plan-adverse-drug-event-prevention
     October 16, 2013 - The three initial high-priority targets of the action plan are anticoagulants , diabetes agents , and … Prevention: inpatient and outpatient measures for reduction of adverse drug events from anticoagulants, diabetes

122. Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors. | PSNet
     psnet.ahrq.gov/issue/differences-strength-expression-product-labels-compounders-and-conventional-manufacturers-may
     April 08, 2020 - September 30, 2015 FDA requires label warnings to prohibit sharing of multi-dose diabetes … October 28, 2020 FDA requires label warnings to prohibit sharing of multi-dose diabetes

123. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/45714/psn-pdf
     December 20, 2017 - Among patients age 65 or older, anticoagulants, diabetes medications, and opioids were most commonly … conclude that preventing ADEs requires attention to older adults and to antibiotic, anticoagulant, diabetes

124. Unintentional therapeutic errors involving insulin in the ambulatory setting reported to poison centers. | PSNet
     psnet.ahrq.gov/issue/unintentional-therapeutic-errors-involving-insulin-ambulatory-setting-reported-poison-centers
     June 06, 2018 - August 6, 2008 Therapeutic errors involving diabetes medications reported to United States … Related Resources Potentially inappropriate prescribing for adults living with diabetes … July 6, 2011 Medication errors common for hospital diabetes.

125. Factors that influence the recognition, reporting and resolution of incidents related to medical devices and other healthcare technologies: a systematic review. | PSNet
     psnet.ahrq.gov/issue/factors-influence-recognition-reporting-and-resolution-incidents-related-medical-devices-and
     July 08, 2015 - event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes … and the American Diabetes Association Diabetes Technology Working Group.

126. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/866196/psn-pdf
     June 26, 2024 - Diagnostic accuracy of artificial intelligence-based automated diabetic retinopathy screening in real-world settings: a systematic review and meta-analysis. June 26, 2024 Joseph S, Selvaraj J, Mani I, et al. Diagnostic accuracy of artificial intelligence-based automated diabetic retinopathy screening in real-world…

127. Creating a culture of safety by coaching clinicians to competence. | PSNet
     psnet.ahrq.gov/issue/creating-culture-safety-coaching-clinicians-competence
     January 10, 2024 - November 9, 2022 Type 1 diabetes defined by severe insulin deficiency occurs after 30 … years of age and is commonly treated as type 2 diabetes.

128. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/44427/psn-pdf
     October 13, 2015 - Using the test case example of a diabetes diagnosis for any patient that had a recorded hemoglobin A1c … value of greater than 7% (a test result that is diagnostic for diabetes), problem list completeness

129. Use duodenoscopes with innovative designs to enhance safety: FDA Safety Communication. | PSNet
     psnet.ahrq.gov/issue/use-duodenoscopes-innovative-designs-enhance-safety-fda-safety-communication
     October 19, 2022 - September 30, 2015 FDA requires label warnings to prohibit sharing of multi-dose diabetes … July 1, 2009 Abbott Diabetes Care blood glucose meters.

130. FDA Drug Safety Communication: FDA cautions about dosing errors when switching between different oral formulations of antifungal Noxafil (posaconazole); label changes approved. | PSNet
     psnet.ahrq.gov/issue/fda-drug-safety-communication-fda-cautions-about-dosing-errors-when-switching-between
     April 08, 2020 - September 30, 2015 FDA requires label warnings to prohibit sharing of multi-dose diabetes … July 10, 2015 FDA requires label warnings to prohibit sharing of multi-dose diabetes

131. Confronting racism in pediatric care. | PSNet
     psnet.ahrq.gov/issue/confronting-racism-pediatric-care
     February 22, 2023 - Citation Related Resources From the Same Author(s) Prevalence of undiagnosed diabetes … identified by a novel electronic medical record diabetes screening program in an urban emergency department

132. Simulation-based training: the missing link to lastingly improved patient safety and health? | PSNet
     psnet.ahrq.gov/issue/simulation-based-training-missing-link-lastingly-improved-patient-safety-and-health
     January 17, 2024 - May 11, 2022 Impact of errors in paper-based and computerized diabetes management with … decision support for hospitalized patients with type 2 diabetes.

133. Diagnostic overshadowing in dentistry. | PSNet
     psnet.ahrq.gov/issue/diagnostic-overshadowing-dentistry
     March 13, 2024 - interactive, telephone-based self-management support program to identify adverse events among ambulatory diabetes … Adverse and potential adverse events among a low-income, urban, ambulatory population with diabetes.

134. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. | PSNet
     psnet.ahrq.gov/issue/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded
     February 15, 2024 - September 30, 2015 FDA requires label warnings to prohibit sharing of multi-dose diabetes … February 15, 2017 FDA requires label warnings to prohibit sharing of multi-dose diabetes

135. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/45123/psn-pdf
     May 07, 2018 - reducing-potentially-fatal-errors-associated-high-doses-insulin-successful-multifaceted https://psnet.ahrq.gov/issue/organizational-culture-team-climate-and-diabetes-care-small-office-based-practices

136. Pharmacist-led admission medication reconciliation before and after the implementation of an electronic medication management system. | PSNet
     psnet.ahrq.gov/issue/pharmacist-led-admission-medication-reconciliation-and-after-implementation-electronic
     January 15, 2025 - November 21, 2021 Type 1 diabetes defined by severe insulin deficiency occurs after 30 … years of age and is commonly treated as type 2 diabetes.

137. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/853433/psn-pdf
     September 13, 2023 - Outcomes of missed diagnosis of pediatric appendicitis, new-onset diabetic ketoacidosis, and sepsis in five pediatric hospitals. September 13, 2023 Michelson KA, Bachur RG, Grubenhoff JA, et al. Outcomes of missed diagnosis of pediatric appendicitis, new-onset diabetic ketoacidosis, and sepsis in five pediatric ho…

138. Medication guides: patient medication information. A proposed rule by the Food and Drug Administration. | PSNet
     psnet.ahrq.gov/issue/medication-guides-patient-medication-information-proposed-rule-food-and-drug-administration
     September 15, 2021 - Prevention: inpatient and outpatient measures for reduction of adverse drug events from anticoagulants, diabetes … May 4, 2015 FDA requires label warnings to prohibit sharing of multi-dose diabetes pen

139. Utilizing pharmacy students in transitions-of-care services. | PSNet
     psnet.ahrq.gov/issue/utilizing-pharmacy-students-transitions-care-services
     October 19, 2022 - October 19, 2022 Type 1 diabetes defined by severe insulin deficiency occurs after 30 … years of age and is commonly treated as type 2 diabetes.

140. Why do hundreds of US women die annually in childbirth? | PSNet
     psnet.ahrq.gov/issue/why-do-hundreds-us-women-die-annually-childbirth
     June 14, 2019 - Download Citation Related Resources From the Same Author(s) Type 1 diabetes … defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes